Search Tag: Ortho Clinical Diagnostics

Executive Health Management

Role of Antigen Tests in the COVID-19 pandemic

2021 17 Feb

Speakers: Dr. Karen Roush, MD, MBA Dr. Lily Li, MD, PhD, MBA Find Ortho Clinical Diagnostics - EMEA on Social Media   Read more

ICU Management

Ortho’s VITROS® B•R•A•H•M•S PCT Assay For Sepsis Now Available

2020 06 Dec

Ortho Clinical Diagnostics , a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, received CE Mark for its VITROS ®  B•R•A•H•M•S PCT (Procalcitonin) assay, now commercially available to help clinicians identify sepsis and other severe bacterial infections. Ortho’s newest assay is available... Read more

Executive Health Management

ORTHO Optix™ Reader Now Available in CE Mark Countries, Completes Transfusion Medicine Portfolio

2020 30 Nov

Ortho Clinical Diagnostics , a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced the CE Mark availability of the semi-automated ORTHO Optix™ Reader, which allows lower-volume transfusion labs to elevate their standard of patient care with the quality of results expected... Read more

Executive Health Management

Ortho’s Next Gen TSH3 Assay to Assess Thyroid and/or Pituitary Disorders Achieves CE Mark

2020 13 Nov

Ortho Clinical Diagnostics , a global leader of in vitro diagnostics, today announced its VITROS® Immunodiagnostic Products TSH3 (Thyroid Stimulating Hormone) Reagent Pack and Calibrator has achieved CE Mark and will be commercially available in the beginning of December* to aid clinicians in assessing and diagnosing thyroid and/or pituitary gland... Read more

ICU Management

Ortho’s VITROS® COVID-19 Antigen Test Capable of Accurate Mass-Scale Testing Achieves CE Mark

2020 26 Oct

Ortho’s new SARS-CoV-2 antigen test offers 98.9% concordance to real-time PCR tests, making it a viable alternative suitable for mass-scale testing Ortho’s new SARS-CoV-2 antigen test is the latest addition to the company’s COVID-19 solutions, which include two CE Marked and FDA EUA COVID-19 antibody tests – Total and IgG Ortho Clinical... Read more

Executive Health Management

Ortho’s VITROS® COVID-19 Antigen Test Capable of Accurate Mass-Scale Testing Achieves CE Mark

2020 26 Oct

Ortho’s new SARS-CoV-2 antigen test offers 98.9% concordance to real-time PCR tests, making it a viable alternative suitable for mass-scale testing Ortho’s new SARS-CoV-2 antigen test is the latest addition to the company’s COVID-19 solutions, which include two CE Marked and FDA EUA COVID-19 antibody tests – Total and IgG Ortho Clinical Diagnostics,... Read more

Executive Health Management

COVID-19 Total Antibody Test from Ortho Clinical Diagnostics Receives CE Mark

2020 12 May

- Ortho’s COVID-19 total antibody test receives CE Mark  -Ortho’s total antibody test may be used as aid in diagnosis and to support decisions for getting people back to work -The test offers excellent performance, with 100 percent specificity and sensitivity -Ortho began shipping its antibody test to customers in highly impacted geographies and plans... Read more